Coagulation Cascade Animation - Physiology of Hemostasis Thrombosis Adviser 2014-03-03 | Coagulation Cascade: description of the physiological process of hemostasis including platelet plug formation and about the intrinsic and extrinsic pathways. More details about the coagulation cascade: thrombosisadviser.com/en/understanding-thrombosis/the-coagulation-cascadeApproval Code: PP-XAR-ALL-2430-1
About the Mechanism of Disease for Chronic Kidney Disease in Type 2 Diabetes Thrombosis Adviser 2020-05-06 | Watch the video to learn more about the mechanism of disease (MOD) for chronic kidney disease in type 2 diabetes. For more information, please visit ckd-info.comExplore the drivers of CKD progression and learn how mineralocorticoid receptor over activation triggers inflammation and fibrosis in the kidney. Approval Number: PP-FINE-ALL-0046-1
What is Peripheral Artery Disease - Mechanism of Disease Thrombosis Adviser 2018-09-27 | Watch the video to get an overview of peripheral artery disease development and pathogenesis, more at thrombosisadviser.com/en/vascular-protection/knowledge-base/peripheral-artery-diseaseApproval Number: AWB-2086315139
What is Coronary Artery Disease - Mechanism of Disease Thrombosis Adviser 2018-09-11 | Watch the video to get an overview of coronary artery disease development and pathogenesis, more at thrombosisadviser.com/en/vascular-protection/knowledge-base/coronary-artery-diseaseApproval Number: AWB-2086315139
What is Peripheral Artery Disease (PAD): Causes and Consequences Thrombosis Adviser 2018-08-20 | Peripheral Artery Disease (PAD) is a progressive, systemic disease resulting from the formation of atherosclerotic plaques in the peripheral arteries, causes stenosis and occlusion, more details at more details at thrombosisadviser.com/en/vascular-protection/knowledge-base/peripheral-artery-diseasePAD is often asymptomatic, but severe vascular obstruction can lead to limb ischaemia requiring amputation. Despite treatment involving antiplatelet therapy and lifestyle changes, patients with Peripheral Artery Disease (PAD) are still at high risk of thrombotic events.Approval Number: G.MKT.GM.XA.08.2017.1695
What is Coronary Artery Disease (CAD) - Causes and Consequences Thrombosis Adviser 2018-08-07 | Coronary Artery Disease is characterized by atherosclerotic plaque formation in the coronary arteries and underlies ischaemic heart disease, the leading cause of death worldwide. More Details at thrombosisadviser.com/en/vascular-protection/knowledge-base/coronary-artery-diseaseRupture of an atherosclerotic plaque can lead to the formation of a blood clot in the artery. This is known as atherothrombosis and can lead to restricted blood flow through the artery, potentially causing myocardial infarction. Although antiplatelet therapy is available to patients with CAD, the residual risk of atherothrombotic events remains high.Approval Number: G.MKT.GM.XA.08.2017.1694
Understanding Atrial Fibrillation - Why Preventing Blood Clots is Crucial Thrombosis Adviser 2018-05-24 | Preventing blood clots in patients with atrial fibrillation is crucial, please contact your local healthcare professional or visit our patient and carers website to get more information about atrial fibrillation at thrombosisadviser.com/atrial-fibrillation
Coagulation Cascade Explained Thrombosis Adviser 2017-07-24 | This video gives you an overview about the Coagulation Cascade. For more information visit our knowledge base thrombosisadviser.com/en/professionals/knowledge-base/essentials/the-coagulation-cascade© Bayer AG, 2021 | Approval number: PP-XAR-ALL-0090-2
Arterial Thrombosis Explained Thrombosis Adviser 2017-07-05 | This video gives you an overview about Arterial Thrombosis, For more information visit our knowledge base thrombosisadviser.com © Bayer AG, 2021 | Approval number: PP-XAR-ALL-0087-2
Venous Thrombosis Explained Thrombosis Adviser 2017-06-28 | This video gives you an overview about Venous Thrombosis, For more information visit our knowledge base thrombosisadviser.com/venous-thrombosis© Bayer AG, 2017 | Approval number: G.MKT.GM.XA.06.2017.1548
Impact of Adherence & Persistence in Patient Outcomes Thrombosis Adviser 2016-03-29 | Treatment adherence and persistence animation explains the impact of adherence and persistence in patient outcomes and quality of life
About Real World Evidence (RWE) Thrombosis Adviser 2016-03-29 | Real World Evidence (RWE) Animation provides an unbranded overview of RWE
Platelet Activation and Factors for Clot Formation Thrombosis Adviser 2014-12-17 | Learn more about the process of platelet activation and the involved coagulation factors triggering clot formation? Find more about clot formation on: thrombosisadviser.com/arterial-thrombosisApproval Number: PP-XAR-ALL-2428-1
Venous Thromboembolism (VTE) Pathology Thrombosis Adviser 2013-12-03 | Venous thromboembolism (VTE) is a leading cause of death worldwide. In the Western world, someone develops a VTE every 16 seconds. Manifestations of the disease are deep vein thrombosis and pulmonary embolism, more at thrombosisadviser.com/en/understanding-thrombosis/venous-thrombosisReferences:Roger VL, Gc AS, Lloyd-Jones DM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics -- 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18-e209Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA. Venous thromboembolism (VTE) in Europe. Thromb Haemost. 2007;98:756-764 EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363(26):2499-2510
A patients perspective of living with Pulmonary Embolism (PE) Thrombosis Adviser 2013-09-18 | A patient talks about his personal experiences of suffering multiple PEs and talks about how this has impacted his daily life in terms of work, family and dietary impact due to his medication.
Post-thrombotic syndrome (PTS) can be a consequence of DVT Thrombosis Adviser 2012-12-14 | If a DVT is not treated properly, there is the risk of developing a complication known as post-thrombotic syndrome (PTS) in the future. A PTS can manifest itself in calf pain, discomfort, swelling, ulcers or rashes.References:Goldhaber SZ, Morrison RB. Pulmonary Embolism and Deep Vein Thrombosis. Circulation 2002; 106: 1436-38Spencer FA, Emercy C, Lessard D, et al. The Worcester Venous Thromboembolism study: a populationbased study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 2006; 21: 722-27Goldhaber SZ. Pulmonary Embolism. N Engl J Med 1998; 339: 93-104Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep vein thrombosis. Ann Intern Med 1996; 125(1): 1-7
DVT can lead to pulmonary embolism (PE) Thrombosis Adviser 2012-12-14 | In DVT, there is the potential danger of a blood clot breaking free and travelling with the blood stream. As a consequence, the clot is able to reach the heart. From there, it can be transported to the arteries of the lungs, where it may become stuck in the smaller vessels, causing a pulmonary embolism (PE).References:Goldhaber SZ, Morrison RB. Pulmonary Embolism and Deep Vein Thrombosis. Circulation 2002; 106: 1436-38Spencer FA, Emercy C, Lessard D, et al. The Worcester Venous Thromboembolism study: a populationbased study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 2006; 21: 722-27Goldhaber SZ. Pulmonary Embolism. N Engl J Med 1998; 339: 93-104Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep vein thrombosis. Ann Intern Med 1996; 125(1): 1-7
About Thrombosis: Symptoms and risk factors for deep vein thrombosis (DVT) Thrombosis Adviser 2012-12-14 | About Thrombosis: Symptoms and risk factors for deep vein thrombosis (DVT). If coagulation is triggered inappropriately, a blood clot can form in one of the large veins in the leg, pelvis, abdomen, or more rarely in the arms, when it's not needed to prevent blood loss. The medical name for this condition is deep vein thrombosis or DVT, more at thrombosisadviser.com/en/vte-treatment/deep-vein-thrombosisReferences:Goldhaber SZ, Morrison RB. Pulmonary Embolism and Deep Vein Thrombosis. Circulation 2002; 106: 1436-38Spencer FA, Emercy C, Lessard D, et al. The Worcester Venous Thromboembolism study: a populationbased study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med. 2006; 21: 722-27Goldhaber SZ. Pulmonary Embolism. N Engl J Med 1998; 339: 93-104Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep vein thrombosis. Ann Intern Med 1996; 125(1): 1-7
Why A Blood Clot Is Serious Thrombosis Adviser 2012-09-17 | Blood clots are responsible for a number of common, serious and often life-threatening conditions, such as venous thromboembolism, stroke from atrial fibrillation or heart attacks.Please note that the video was created in 2012. At that time, one study found that even with the current therapeutic approaches, a 10% risk of heart attack, stroke or death within one year of an event remained. With the approaches available today, risk rates may be different.References:Cohen et al. Thromb Haemost 2007;98:756-64Marini et al. Stroke 2005;36(6):115-9Wallentin et al. N Engl J Med 2009;361(11):1045-57Approval Code: PP-XAR-ALL-2433-1
Atrial Fibrillation Animation Explained: AFib & Risk of Stroke Thrombosis Adviser 2012-01-04 | Atrial fibrillation (AF) is the most common sustained arrhythmia seen in clinical practice, affecting more than 6 million people in Europe, up to 5.1 million people in the US and more than 800,000 people in Japan. Atrial fibrillation AFib is associated with a major risk of stroke, caused by a thrombus that forms within the left atrium and embolises to block a cerebral artery. The degree of stroke risk and the need for anticoagulant therapy to lower this risk varies among patients with AF. More info and references: http://www.thrombosisadviser.com/en/stroke-prevention-in-af/af-is-a-major-stroke-risk-factor
